|
Medpace Holdings ، Inc. (MEDP) DCF تقييم
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Medpace Holdings, Inc. (MEDP) Bundle
تكشف عن الإمكانات الحقيقية لـ MedPace Holdings ، Inc. (MEDP) مع حاسبة DCF على مستوى الخبراء! اضبط الافتراضات الهامة واستكشاف السيناريوهات المختلفة وتقييم كيفية تأثير التغييرات المختلفة على تقييم MedPace Holdings ، Inc. (MEDP) - كل ذلك ضمن قالب Excel الشامل.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 925.9 | 1,142.4 | 1,460.0 | 1,885.8 | 2,109.1 | 2,595.1 | 3,193.2 | 3,929.1 | 4,834.6 | 5,948.7 |
| Revenue Growth, % | 0 | 23.38 | 27.8 | 29.17 | 11.84 | 23.05 | 23.05 | 23.05 | 23.05 | 23.05 |
| EBITDA | 186.6 | 219.7 | 301.0 | 363.2 | 446.9 | 521.3 | 641.5 | 789.3 | 971.2 | 1,195.1 |
| EBITDA, % | 20.15 | 19.23 | 20.62 | 19.26 | 21.19 | 20.09 | 20.09 | 20.09 | 20.09 | 20.09 |
| Depreciation | 33.5 | 37.4 | 40.4 | 26.3 | .0 | 57.3 | 70.6 | 86.8 | 106.8 | 131.4 |
| Depreciation, % | 3.61 | 3.27 | 2.76 | 1.4 | 0 | 2.21 | 2.21 | 2.21 | 2.21 | 2.21 |
| EBIT | 153.1 | 182.3 | 260.7 | 336.8 | 446.9 | 464.0 | 570.9 | 702.5 | 864.4 | 1,063.6 |
| EBIT, % | 16.54 | 15.96 | 17.85 | 17.86 | 21.19 | 17.88 | 17.88 | 17.88 | 17.88 | 17.88 |
| Total Cash | 277.8 | 461.3 | 28.3 | 245.4 | 669.4 | 607.6 | 747.7 | 920.0 | 1,132.0 | 1,392.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 161.0 | 186.4 | 253.4 | 298.4 | 296.4 | 420.1 | 516.9 | 636.0 | 782.6 | 963.0 |
| Account Receivables, % | 17.38 | 16.32 | 17.36 | 15.82 | 14.06 | 16.19 | 16.19 | 16.19 | 16.19 | 16.19 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 26.6 | 25.7 | 33.1 | 31.9 | 32.5 | 55.1 | 67.8 | 83.4 | 102.6 | 126.3 |
| Accounts Payable, % | 2.87 | 2.25 | 2.27 | 1.69 | 1.54 | 2.12 | 2.12 | 2.12 | 2.12 | 2.12 |
| Capital Expenditure | -31.3 | -28.3 | -36.9 | -36.6 | .0 | -53.6 | -66.0 | -81.2 | -99.9 | -122.9 |
| Capital Expenditure, % | -3.38 | -2.47 | -2.53 | -1.94 | 0 | -2.07 | -2.07 | -2.07 | -2.07 | -2.07 |
| Tax Rate, % | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 | 15.03 |
| EBITAT | 131.7 | 163.8 | 226.0 | 283.8 | 379.7 | 400.7 | 493.0 | 606.7 | 746.5 | 918.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -.6 | 146.6 | 169.9 | 227.3 | 382.3 | 303.3 | 413.5 | 508.8 | 626.0 | 770.3 |
| WACC, % | 10.38 | 10.39 | 10.39 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,884.1 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 797 | |||||||||
| Terminal Value | 11,580 | |||||||||
| Present Terminal Value | 7,066 | |||||||||
| Enterprise Value | 8,950 | |||||||||
| Net Debt | -543 | |||||||||
| Equity Value | 9,493 | |||||||||
| Diluted Shares Outstanding, MM | 32 | |||||||||
| Equity Value Per Share | 296.53 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real MEDP financials.
- Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Medpace’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Customizable Forecast Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital expenditures.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and additional outputs with ease.
- High-Precision Accuracy: Leverages Medpace's actual financial data for credible valuation results.
- Streamlined Scenario Analysis: Effortlessly explore various assumptions and assess outcomes.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- 1. Access the Template: Download and open the Excel file containing Medpace Holdings, Inc. (MEDP) preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to investigate different valuation results.
- 5. Present with Assurance: Showcase professional valuation insights to back your decisions.
Why Choose This Calculator for Medpace Holdings, Inc. (MEDP)?
- Accurate Data: Utilize real Medpace financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Ready-to-use calculations save you from starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions make it accessible for all users.
Who Should Use This Product?
- Clinical Research Professionals: Enhance your understanding of trial methodologies and apply them using real-world data.
- Academics: Integrate advanced clinical models into your teaching or research initiatives.
- Investors: Evaluate your investment strategies and analyze valuation metrics for Medpace Holdings, Inc. (MEDP).
- Analysts: Optimize your analysis process with a pre-configured, adaptable financial model.
- Healthcare Entrepreneurs: Discover how major clinical research organizations like Medpace are evaluated.
What the Template Contains
- Pre-Filled DCF Model: Medpace Holdings, Inc.'s (MEDP) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Medpace's profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.